| Acronym | Full-Extensive name |
| ACAN | Aggrecan |
| ADAMTs | a disintegrin and metalloproteinase with thrombospondin motifs |
| AGEs | advanced glycation end-products |
| Arg1 | arginase-1 |
| BCP | basic calcium phosphate |
| BDNF | brain-derived neurotrophic factor |
| BDMs | bioactive dietary molecules |
| BDNF | brain-derived neurotrophic factor |
| CCL | Chemokine (C-C motif) ligand |
| CFA | complete Freund’s adjuvant |
| CGRP | calcitonin gene-related peptide |
| ChPF | Chondroitin Polymerizing Factor |
| CHSY-1 | Chondroitin sulfate synthase 1 |
| COX-2 | cyclooxygenase-2 |
| CPPD | Calcium pyrophosphate dihydrate |
| CRP | C-reactive protein |
| CSPG | Chondroitin sulfate proteoglycans |
| CXCL | C-X-C Motif Chemokine Ligand |
| DAMPs | damage-associated molecular patterns |
| DEC | Decorin core protein |
| DRG | dorsal root ganglia |
| ECM | extracellular matrix |
| EFSA | European Food Safety Authority |
| ERK | extracellular signal regulated kinase |
| FMN | Formononetin |
| GABA | Gamma-aminobutyric acid |
| GAGs | Glycosamminoglycans |
| GSH | reduced glutathione |
| GSSG | oxidized disulfide form glutathione |
| GSTA4-4 | glutathione-s-tranferase A4-4 |
| H2O2 | produces hydrogen peroxide |
| HA | hyaluronic acid |
| HMGB1 | high-mobility group box-1 |
| HNE | 4-hydroxynonenal |
| HNE | 4-hydroxynonenal |
| IA | intra-articular |
| IL | Interleukin |
| IL1-R | interleukin-1 receptor |
| iNOS | inducible NO synthase |
| JNK | c-Jun NH2-terminal kinase |
| KOOS | Knee injury and Osteoarthritis Outcome Score |
| LGI | low-grade inflammation |
| MAPK | mitogen-activated protein kinase |
| MCP-1, CCL2 | monocyte chemoattractant protein-1 |
| MIA | mono-iodoacetate |
| miR | miRNA |
| MMPs | matrix metalloproteinases |
| MWT | mechanical withdrawal threshold |
| NE | nor-epinephrine |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NGF | nerve growth factor |
| NK | neurokinin |
| NLRP3 | nucleotide-binding oligomerization domain-like receptor protein 3 |
| NLRs | NOD-like receptors |
| NMDA | N-methyl-D-aspartate |
| NO | nitric oxide |
| NOX | NADPH Oxidase |
| NSAIDs | non-steroidal anti-inflammatory drugs |
| OA | osteoarthritis |
| OSM | oncostatin M |
| PG | Proteoglycans |
| PGE2 | prostaglandin E2 |
| PI3K/ AKT | phosphoinositide 3-kinase/protein kinase B |
| PLGA | poly lactic-co-glycolic acid |
| PPs | polyphenols |
| PRP | Platelet-rich plasma |
| PRRs | pattern recognition receptors |
| PTGS2 | prostaglandin-endoperoxide synthase 2 |
| PWL | paw withdrawal latency |
| PWT | paw withdrawal threshold |
| RAGEs | receptor for advanced glycosylation end products |
| ReHo | Regional homogeneity |
| ROM | Range of motion |
| ROS | Reactive oxygen species |
| Rsv | Resveratol |
| Runx-2 | runt-related transcription factor 2 |
| SASP | senescence-associated secretory phenotype |
| Sox-9 | SRY-box transcription factor 9 |
| SP | substance P |
| TGF- β | transforming growth factor β |
| TBHP | tert-butylhydroperoxide |
| TKA | total knee arthroplasty |
| TLR | toll-like receptors |
| TNF-α | tumor necrosis factor-α |
| TRIF | TIRdomain-containing adaptor-inducing interferon-β |
| TrK | tropomyosin receptor kinase |
| TRP | Transient receptor potential |
| TrpV1 | Transient receptor potential cation channel subfamily V member 1 |
| TWL | thermal withdrawal latency |
| VAS | Visual Analogh scale |
| VEGF | vascular endothelial growth factor |
| WOMAC | Western Ontario and McMaster Universities Arthritis Index |
| XT | Xylosyltransferase |
| Ym1 | chitinase 3-like protein 3 |